. [eighty two] to evaluate the efficacy, protection and tolerability of Cannabidiol being an adjunct therapy coupled with anti-epileptic medications around the people struggling from tuberous sclerosis advanced whose most commonly encountered neurological symptom is epilepsy. With this clinical trial research, following treatment method with Cannab